4^th Translational Research Conference:
Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia

March 14-16, 2025 – Malahide (Dublin), Ireland

#ESHERYTHRO2025

Chairs: Maria-Domenica Cappellini, Michaela Fontenay, Alexis A. Thompson

REGISTRATION AND ABSTRACT SUBMISSION ARE OPEN!

SCIENTIFIC TOPICS:
– Update on pathophysiology on sickle cell disease, thalassemia and normal red blood cell
– Iron and erythropoiesis
– Inflammation in sickle cell disease
– Dyserythopoiesis in thalassemia
– Premature aging in sickle cell and thalassemia
– Fetal hemoglobin control
– Novel pharmacologic approaches to sickle cell disease and thalassemia
– Novel genomic approaches to sickle cell and thalassemia
– Cases discussions

LEARNING OBJECTIVES:
Upon completion of this CME activity, participants will learn about:
– Increasing our understanding of regulatory mechanisms of erythropoiesis
– Post-transcriptional regulation of erythropoiesis
– Listing the causes of ineffective erythropoiesis and the potential targets for innovative treatments

THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Simultaneous Meet the Experts Sessions
– Round Table Discussions
– Poster Presentations
– Short Oral Communications
– Ample time for in-depth discussion

This meeting will be valuable to you if you are looking for:
– A cutting-edge scientific program – from basic science to clinical and therapeutic applications and perspectives
– Multiple opportunities for scientific interaction with an international faculty of distinguished experts
– An emphasis on critical discussion
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.